Exhibit 99.1 Contact:Trinity Biotech plc Lytham Partners, LLC John Gillard Joe Diaz (353)-1-2769800 (1)-602-8 89-9700 E-mail: investorrelations@trinitybiotech.com Trinity Biotech Announces Q2 2023 Financial Results DUBLIN, Ireland (October 3, 2023)... Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Company’s results for the quarter ended June 30, 2023. Summary Highlights: Revenue: • Tot ...